- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-05
DOI
10.3389/fphar.2021.518345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
- (2020) Jonathan E. Phillips Frontiers in Pharmacology
- Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors
- (2020) Marta Joskova et al. Frontiers in Pharmacology
- Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
- (2020) Viera Janosova et al. Frontiers in Pharmacology
- Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
- (2019) Dirkje S Postma et al. Lancet Respiratory Medicine
- Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials
- (2019) Mingjin Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long-term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple-Dummy Clinical Trial
- (2018) Kenneth R Chapman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of roflumilast on chronic obstructive pulmonary disease: a systematic review and meta-analysis
- (2018) Lu-Fei Shen et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibitors of phosphodiesterases in the treatment of cough
- (2018) Juraj Mokry et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- The effect of surgical weight loss on obstructive sleep apnoea: A systematic review and meta-analysis
- (2018) Ai-Ming Wong et al. SLEEP MEDICINE REVIEWS
- Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
- (2018) Henrik Watz et al. International Journal of Chronic Obstructive Pulmonary Disease
- Bronchiectasis: new therapies and new perspectives
- (2018) James D Chalmers et al. Lancet Respiratory Medicine
- Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial
- (2018) Peter M A Calverley et al. Lancet Respiratory Medicine
- Clinical Approach to the Therapy of Asthma-COPD Overlap
- (2018) Diego J. Maselli et al. CHEST
- Inhaled corticosteroids in COPD: Friend or foe?
- (2018) Alvar Agusti et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
- (2018) Xiaoli Zhang et al. Drug Design Development and Therapy
- Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
- (2018) Klaus F Rabe et al. Lancet Respiratory Medicine
- Direct Inhibitory Effect of the Phosphodiesterase-4 Inhibitor, Roflumilast, on Neutrophil Migration in COPD
- (2018) Amy E Dunne et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pulmonary hypertension in chronic lung disease and hypoxia
- (2018) Steven D. Nathan et al. EUROPEAN RESPIRATORY JOURNAL
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice
- (2017) Hussam A Murad et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial
- (2017) Patrizio Vitulo et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Cough and airway disease: The role of ion channels
- (2017) Sara J. Bonvini et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Sarcopenia correlates with systemic inflammation in COPD
- (2017) Min Kwang Byun et al. International Journal of Chronic Obstructive Pulmonary Disease
- Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases
- (2017) Theerasuk Kawamatawong Journal of Thoracic Disease
- Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
- (2016) Dave Singh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND). A Randomized Clinical Trial
- (2016) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of roflumilast on airway remodelling in a murine model of chronic asthma
- (2016) S. W. Kim et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
- (2016) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
- (2016) Jadwiga A. Wedzicha et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients
- (2016) D. Singh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A Distinct Lung-Interstitium-Resident Memory CD8 + T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection
- (2016) Pavlo Gilchuk et al. Cell Reports
- Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA
- (2016) Bita Hajian et al. International Journal of Chronic Obstructive Pulmonary Disease
- Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial
- (2016) R Andrew McIvor et al. Canadian Respiratory Journal
- ABCD of the phosphodiesterase family: interaction and differential activity in COPD
- (2016) David Halpin International Journal of Chronic Obstructive Pulmonary Disease
- Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure
- (2015) Jean Tyrrell et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease
- (2015) J. Michael Wells et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist–Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells
- (2015) Brijeshkumar S. Patel et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial
- (2015) Fernando J Martinez et al. LANCET
- Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies
- (2015) E.D. Bateman et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Roflumilast for asthma: Efficacy findings in mechanism of action studies
- (2015) P. Bardin et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
- (2015) Alfredo Chetta et al. International Journal of Chronic Obstructive Pulmonary Disease
- Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases
- (2014) Katharine H. Abbott-Banner et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Emergency treatment of status asthmaticus with enoximone
- (2014) J. Beute BRITISH JOURNAL OF ANAESTHESIA
- The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
- (2014) W. De Backer et al. EUROPEAN RESPIRATORY JOURNAL
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
- (2014) Helgo Magnussen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Obesity on the Clinical Profile of a Population-Based Sample with Chronic Obstructive Pulmonary Disease
- (2014) Francisco García-Rio et al. PLoS One
- Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and meta-analysis
- (2014) Lana J. Mitchell et al. SLEEP MEDICINE
- The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
- (2014) Brian R Leaker et al. BMC Pulmonary Medicine
- Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases
- (2013) Bianca Beghè et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Structural basis for the design of selective phosphodiesterase 4B inhibitors
- (2013) David Fox et al. CELLULAR SIGNALLING
- Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
- (2013) William B. White et al. CHEST
- Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
- (2013) Jadwiga A. Wedzicha et al. CHEST
- Roflumilast for the Treatment of COPD in an Asian Population
- (2013) Jinping Zheng et al. CHEST
- Roflumilast Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α and Chemokine Production by Human Lung Parenchyma
- (2013) Amparo Buenestado et al. PLoS One
- Pre-clinical studies in cough research: Role of Transient Receptor Potential (TRP) channels
- (2013) Megan S. Grace et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Intranasal Theophylline Treatment of Hyposmia and Hypogeusia
- (2012) Robert I. Henkin et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro
- (2012) J Milara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Selective PDE inhibitors as novel treatments for respiratory diseases
- (2012) Clive P Page et al. CURRENT OPINION IN PHARMACOLOGY
- Sinonasal inflammation in COPD: a systematic review: Table 1–
- (2012) Kåre Håkansson et al. EUROPEAN RESPIRATORY JOURNAL
- TRP channels as therapeutic targets in airway disorders: a patent review
- (2012) Delia Preti et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Macrolide Therapy in Chronic Inflammatory Diseases
- (2012) Kazuhito Asano et al. MEDIATORS OF INFLAMMATION
- Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
- (2012) Zeenat Safdar et al. International Journal of Chronic Obstructive Pulmonary Disease
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
- (2011) Klaus F. Rabe BRITISH JOURNAL OF PHARMACOLOGY
- PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease
- (2011) J M Michalski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PDE3 inhibition in dilated cardiomyopathy
- (2011) Matthew Movsesian et al. CURRENT OPINION IN PHARMACOLOGY
- Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
- (2011) John E. McDonough et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea
- (2010) Jose M. Marin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Global Airway Disease Beyond Allergy
- (2010) Peter W. Hellings et al. CURRENT ALLERGY AND ASTHMA REPORTS
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
- (2010) Sergey Udalov et al. BMC Pulmonary Medicine
- PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-β1-stimulated fibroblasts
- (2009) Shinsaku Togo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function
- (2009) Maria Grandoch et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
- (2009) M. Metra et al. EUROPEAN HEART JOURNAL
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- (2009) Leonardo M Fabbri et al. LANCET
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- (2009) Peter MA Calverley et al. LANCET
- Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: The MONtelukast In Chronic Asthma (MONICA) study
- (2009) J. Christian Virchow et al. RESPIRATORY MEDICINE
- Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease
- (2009) Giuseppe Valerio et al. Therapeutic Advances in Respiratory Disease
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
- (2008) J. Bousquet et al. ALLERGY
- Severe Exacerbations and Decline in Lung Function in Asthma
- (2008) Paul M. O'Byrne et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Overlap Syndrome: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea
- (2008) David Hiestand et al. CRITICAL CARE CLINICS
- The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide
- (2007) Jadwiga A. Wedzicha et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started